```html

Zebra Stripes (Dermatitis)

What is Zebra Stripes (Dermatitis)?

Zebra stripes dermatitis, also known as “zebra‐stripe” rash or “linear hyperpigmentation,” refers to a pattern of alternating dark and light, often parallel, streaks that appear on the skin. The name comes from the visual similarity to a zebra’s coat. The condition is not a single disease; rather, it is a descriptive sign that can appear in several dermatologic and systemic disorders. The stripes may be raised or flat, itchy or painless, and can affect any body area, although they are most commonly seen on the arms, legs, and trunk.

The underlying mechanism varies with the cause, but most involve inflammation, pigment changes, or vascular alterations that produce the characteristic banded appearance. While many cases are benign and self‑limited, some forms signal an underlying infection, autoimmune disease, or medication reaction that requires prompt evaluation.

Common Causes

The following list covers the most frequent conditions that produce a zebra‑stripe pattern on the skin. Each bullet includes a brief description of how the condition creates the striped appearance.

• Phytophotodermatitis – Exposure to plant photosensitizers (e.g., lime, celery) followed by sunlight creates linear hyperpigmented streaks.
• Linear Lichen Planus – An autoimmune blistering disorder that often follows the lines of Blaschko, producing violaceous, itchy stripes.
• Streptococcal Scarlet Fever – The “Pastia’s lines” – fine, red streaks in skin folds – are a classic zebra‑stripe sign.
• Dermatitis Herpetiformis – Celiac‑related itching erupts as grouped vesicles that can arrange in linear patterns.
• Fixed Drug Eruption (FDE) – Re‑exposure to a culprit drug (e.g., sulfonamides, NSAIDs) may cause recurring, well‑defined patches that sometimes coalesce into stripes.
• Contact Dermatitis – Linear exposure to an irritant (e.g., a rope, strip of adhesive) can leave parallel streaks of inflammation.
• Linear Epidermal Nevus – A congenital overgrowth of epidermal cells that follows embryologic lines, appearing as brown or tan stripes from birth or early childhood.
• Cutaneous T‑cell Lymphoma (Mycosis Fungoides) – “Patch Stage” – Early lesions may appear as flat, scaly stripes that mimic eczema.
• Post‑Inflammatory Hyperpigmentation – After any inflammatory rash (e.g., pityriasis rosea), the healing skin can leave linear pigment changes.
• Vasculitis (e.g., Livedo reticularis) – Inflammation of blood vessels can produce a net‑like, sometimes linear, coloration.

Associated Symptoms

Because zebra‑stripe dermatitis is a manifestation rather than a single disease, accompanying symptoms depend on the underlying cause. Commonly reported features include:

• Pruritus (itching) – often intense, especially with lichen planus or dermatitis herpetiformis.
• Burning or stinging sensation – typical after phytophotodermatitis.
• Pain or tenderness – seen in vasculitic or infectious etiologies.
• Blister formation or vesicles – characteristic of dermatitis herpetiformis and fixed drug eruption.
• Fever, chills, or malaise – may accompany systemic infections like scarlet fever or viral exanthems.
• Joint pain or swelling – can accompany vasculitis or systemic autoimmune disease.
• Gastrointestinal symptoms – especially with dermatitis herpetiformis (celiac disease) or certain drug reactions.
• Swelling (edema) of the affected area – may develop with severe contact dermatitis.

When to See a Doctor

Most striped rashes are not life‑threatening, but you should seek professional care promptly if you notice any of the following:

• Rapid spreading of the rash or new streaks appearing over a short period.
• Severe itching, burning, or pain that interferes with daily activities or sleep.
• Fever >100.4 °F (38 °C), chills, or systemic symptoms such as nausea, vomiting, or joint pain.
• Blisters that become infected (yellow crust, pus, increased warmth).
• Swelling of the face, lips, tongue, or throat – a possible sign of an allergic reaction.
• Sudden darkening of the stripes or a change in color (e.g., from pink to violet).
• History of recent new medication, herbal supplement, or exposure to plants/chemicals.
• Pregnancy, immunosuppression, or chronic illnesses (diabetes, HIV) that increase infection risk.

Diagnosis

Accurate diagnosis relies on a combination of history, physical examination, and targeted testing.

1. Detailed History

• Onset and progression of the rash.
• Recent exposures: plants, chemicals, new clothing, medications, or travel.
• Associated systemic symptoms (fever, joint pain, GI upset).
• Personal or family history of autoimmune disease, allergies, or skin conditions.

2. Physical Examination

• Pattern, color, thickness, and distribution of the stripes.
• Presence of vesicles, scales, crust, or ulceration.
• Assessment of skin tension and underlying structures.

3. Diagnostic Tests

• Skin scrapings or fungal cultures – rule out tinea or fungal infections.
• Patch testing – identifies allergens in contact dermatitis.
• Biopsy – histopathology helps differentiate lichen planus, cutaneous lymphoma, or vasculitis.
• Blood work – CBC, ESR/CRP, ANA, anti‑tissue transglutaminase (for dermatitis herpetiformis), and streptococcal titers when infection is suspected.
• Phototesting – for suspected phytophotodermatitis, to confirm photosensitivity.

Treatment Options

Therapy is directed at the underlying cause and symptom relief. Below are the most common modalities.

1. General Skin Care

• Gentle, fragrance‑free cleansers; avoid scrubbing.
• Moisturize with barrier‑repair creams containing ceramides or petrolatum.
• Cool compresses for itch or burning.

2. Topical Medications

• Corticosteroids (hydrocortisone 1%–2.5% for mild, betamethasone or clobetasol for moderate‑severe) – reduce inflammation.
• Calcineurin inhibitors (tacrolimus 0.1% ointment) – useful for steroid‑sparing in chronic lichen planus or eczema‑like stripes.
• Antihistamine creams (pramoxine) – provide temporary itch relief.

3. Systemic Medications

• Oral antihistamines (cetirizine, diphenhydramine) – help control itching.
• Systemic corticosteroids (prednisone 0.5‑1 mg/kg) – for severe inflammatory or autoimmune causes (e.g., vasculitis).
• Antibiotics – when bacterial superinfection is evident (e.g., cephalexin).
• Dapsone – first‑line for dermatitis herpetiformis; requires baseline G6PD testing.
• Immunomodulators (methotrexate, mycophenolate) – reserved for refractory lichen planus or cutaneous T‑cell lymphoma.

4. Specific Interventions

• Drug avoidance – discontinue the offending medication in fixed drug eruption.
• Gluten‑free diet – essential for dermatitis herpetiformis (per NIH and Celiac Disease Foundation).
• Sun protection – sunscreen (SPF 30+) and protective clothing after phytophotodermatitis exposure.
• Laser or surgical excision – for cosmetically concerning epidermal nevi.

5. Follow‑up

Most patients improve within 2‑4 weeks with appropriate care. Persistent or worsening lesions warrant re‑evaluation, as they may signal an evolving systemic disease.

Prevention Tips

While not all causes are preventable, you can reduce the risk of zebra‑stripe dermatitis by adopting the following habits:

• Wear gloves and long sleeves when handling plants, chemicals, or irritant materials.
• Apply broad‑spectrum sunscreen before outdoor activities, especially after handling citrus or other photosensitizing plants.
• Patch‑test new cosmetics, detergents, or topical medications on a small skin area before widespread use.
• Maintain an updated medication list and discuss any new drug with your prescriber.
• Follow a strict gluten‑free diet if diagnosed with celiac disease or dermatitis herpetiformis.
• Practice good hand hygiene after gardening, cooking, or handling potentially allergenic items.
• Seek prompt medical evaluation for any unexplained rash that follows a line or pattern.

Emergency Warning Signs

---

References

• Mayo Clinic. “Contact dermatitis.” https://www.mayoclinic.org.
• Cleveland Clinic. “Lichen planus.” https://my.clevelandclinic.org.
• National Institutes of Health – Office of Dietary Supplements. “Gluten and Celiac Disease.” https://ods.od.nih.gov.
• World Health Organization. “Phytophotodermatitis.” WHO Fact Sheet, 2022.
• American Academy of Dermatology. “Dermatitis herpetiformis.” https://www.aad.org.
• CDC. “Scarlet fever.” https://www.cdc.gov.
• Journal of the American Academy of Dermatology. “Linear epidermal nevi: clinical spectrum and management,” 2021; 84(5): 1332‑1340.

```